IXHL · Insider Trading
Incannex Healthcare Limited Common Stock
Every open-market purchase and sale reported by IXHL officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-11-14 | George Anastassov | Director | A | +1,686,956 | — |
| 2025-11-14 | Joseph Swan | CFO, Treasurer and Secretary | A | +869,565 | — |
| 2025-11-14 | Joel Latham | CEO and President | A | +22,608,692 | — |
| 2025-11-14 | Robert Clark | Director | A | +1,686,956 | — |
| 2025-11-14 | Peter Widdows | Director | A | +1,686,956 | — |
| 2025-11-14 | Troy Valentine | Director | A | +11,302,608 | — |
| 2024-10-24 | Luigi M. Barbato | Chief Medical Officer | A | +100,476 | — |
| 2023-12-21 | Robert Clark | Director | A | +100,000 | — |
| 2023-12-21 | George Anastassov | Director | A | +100,000 | — |
| 2023-12-21 | Peter Widdows | Director | A | +100,000 | — |
| 2023-12-21 | Joel Latham | CEO and President | A | +1,340,000 | — |
| 2023-12-21 | Troy Valentine | Director | A | +670,000 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Joel Latham | CEO and President | 806,206 | $2.50M |
| Troy Valentine | Director | 400,395 | $1.24M |
| George Anastassov | Director | 81,889 | $253.86K |
| Peter Widdows | Director | 65,260 | $202.31K |
| Robert Clark | Director | 59,565 | $184.65K |
| Joseph Swan | CFO, Treasurer and Secretary | 30,712 | $95.21K |
| Luigi M. Barbato | Chief Medical Officer | 3,349 | $10.38K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the IXHL quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.